Protective Effect of Luminal Uric Acid Against Indomethacin-Induced Enteropathy: Role of Antioxidant Effect and Gut Microbiota

• Published in: Digestive diseases and sciences 2022-01, Vol.67 (1), p.121-133
• Main Authors: Wada, Akinori, Higashiyama, Masaaki, Kurihara, Chie, Ito, Suguru, Tanemoto, Rina, Mizoguchi, Akinori, Nishii, Shin, Inaba, Kenichi, Sugihara, Nao, Hanawa, Yoshinori, Horiuchi, Kazuki, Shibuya, Naoki, Akiyama, Misaki, Okada, Yoshikiyo, Watanabe, Chikako, Komoto, Shunsuke, Tomita, Kengo, Takei, Fumie, Hokari, Ryota
• Format: Article
• Language: English
• Subjects: Animals; Anti-Inflammatory Agents, Non-Steroidal - pharmacology; Antioxidants; Antioxidants - metabolism; Biochemistry; Biological diversity; Disease Models, Animal; Fecal Microbiota Transplantation - methods; Gastroenterology; Gastrointestinal Microbiome - drug effects; Gastrointestinal Microbiome - immunology; Hepatology; Indomethacin; Indomethacin - pharmacology; Intestinal Diseases - chemically induced; Intestinal Diseases - metabolism; Intestinal Diseases - microbiology; Intestinal Diseases - therapy; Intestine, Small - metabolism; Intestine, Small - microbiology; Medical research; Medicine; Medicine & Public Health; Medicine, Experimental; Mice; Microbiota; Microbiota (Symbiotic organisms); Oncology; Original Article; Oxidative stress; Oxidative Stress - drug effects; Protective Factors; Reactive oxygen species; Reactive Oxygen Species - analysis; Transplant Surgery; Treatment Outcome; Uric acid; Uric Acid - blood; Uric Acid - metabolism
• ISSN: 0163-2116; 1573-2568
• DOI: 10.1007/s10620-021-06848-z

Background Uric acid (UA) has anti- and pro-inflammatory properties. We previously revealed that elevated serum UA levels provide protection against murine small intestinal injury probably via luminal UA secreted in the small intestine. Luminal UA may act as an antioxidant, preventing microbiota vulnerability to oxidative stress. However, whether luminal UA is increased under hyperuricemia and plays a protective role in a dose-dependent manner as well as the mechanism by which luminal UA exerts its protective effects on enteropathy remains unknown. Methods Inosinic acid (IMP) (1000 mg/kg, i.p.) was administered to obtain high serum UA (HUA) and moderate serum UA (500 mg/kg IMP, i.p.) mice. UA concentrations and levels of oxidative stress markers in the serum and intestine were measured. Mice received indomethacin (20 mg/kg, i.p.) to evaluate the effects of UA on indomethacin-induced enteropathy. Reactive oxygen species (ROS) on the ileal mucosa were analyzed. The fecal microbiota of HUA mice was transplanted to investigate its effect on indomethacin-induced enteropathy. Results IMP increased luminal UA dose-dependently, with higher levels of luminal antioxidant markers. Indomethacin-induced enteropathy was significantly ameliorated in both UA-elevated groups, with decreased indomethacin-induced luminal ROS. The microbiota of HUA mice showed a significant increase in α -diversity and a significant difference in β -diversity from the control. Fecal microbiota transplantation from HUA mice ameliorated indomethacin-induced enteropathy. Conclusions The protective role of luminal UA in intestinal injury is likely exerted via oxidative stress elimination and microbiota composition modulation, preferably for gut immunity. Therefore, enhancing anaerobic conditions using antioxidants is a potential therapeutic target.